Injectable Hydrogel of Chitosan-Octyl Itaconate Conjugate Modulates Inflammatory Response DOI
Shasha Zhou, Jibing He, Quan Liu

et al.

ACS Biomaterials Science & Engineering, Journal Year: 2024, Volume and Issue: 10(8), P. 4823 - 4838

Published: July 26, 2024

Itaconic acid and its derivative 4-octyl itaconate (OI) represent a novel anti-inflammatory medication that has demonstrated efficacy in multiple inflammation models because of minimal side effects. Recently, natural polymers conjugated with small molecule drugs, known as polymer-drug conjugates (PDCs), have emerged promising approach to sustained drug release. In this work, we reported an prepare PDC containing OI make it into injectable hydrogel. Chitosan (CS) was selected for synthesis abundant free amino groups can be molecules carboxyl by carbodiimide chemistry. We used ethanol/water cosolvent system synthesize CS-OI conjugate via EDC/NHS catalysis. The had improved water solubility unique activity did not show compromised antibacterial compared unmodified CS. Beta-glycerophosphate (β-GP) cross-linked hydrogel exhibited good injectability sustainable release effectively modulated inflammatory response rat model. Therefore, study provides valuable insights the design hydrogels modulatory properties.

Language: Английский

Four-octyl itaconate improves osteoarthritis by enhancing autophagy in chondrocytes via PI3K/AKT/mTOR signalling pathway inhibition DOI Creative Commons
Xuekang Pan,

Huajian Shan,

Jinyu Bai

et al.

Communications Biology, Journal Year: 2022, Volume and Issue: 5(1)

Published: June 29, 2022

Osteoarthritis (OA) is a highly prevalent and chronic disorder that associated with substantial social economic burden. Itaconate, as an important regulator of cellular inflammation, metabolite synthesised by enzyme encoded immune-responsive gene 1. However, there are few studys regarding the effects itaconate on OA. Here, we show effect cell-permeable derivative 4-octyl (OI) OI attenuates chondrocyte apoptosis induced interleukin 1β (IL-1β) in vitro, indicating protect chondrocytes against apoptosis. Moreover, ameliorates autophagy inhibition IL-1β via PI3K/AKT/mTOR signalling pathway. Finally, enhances reduces cartilage degradation rat model OA established destabilization medial meniscus (DMM). In summary, our findings reveal involved regulating progression The above results shed light treatment

Language: Английский

Citations

36

Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation DOI Creative Commons
Xuzhuo Chen, Chang Li, Xiankun Cao

et al.

Theranostics, Journal Year: 2022, Volume and Issue: 12(7), P. 3251 - 3272

Published: Jan. 1, 2022

Rationale: Inflammatory macrophages and osteoclasts (OCs) play critical roles in joint inflammation, which feature the excessive production of reactive oxygen species (ROS), resulting synovial inflammation bone erosion.Scavenging ROS, especially by modulating mitochondrial metabolic activity, could be a desirable strategy for management inflammatory joints.This study aimed to develop mitochondria-targeted supramolecular drug delivery system with exogenous endogenous ROS-scavenging activities treatment inflammation.Methods: In this study, we utilized zinc-based metal-organic supercontainer (MOSC) as proton sponge electron reservoir outstanding binding capacity, extracellular ability, biocompatibility establish an efficient nanocarrier endo/lysosomal escape targeting.4-Octyl itaconate (4-OI), derivative, served loaded guest construction synergistic therapeutic OCs.Results: After effective encapsulation 4-OI, 4-OI@Zn-NH-pyr not only exhibited potent but also reduced ROS mediating respiration macrophages.Regarding its anti-inflammatory efficacy, ameliorated reaction activating nuclear factor erythroid 2-related 2 (Nrf2), thus increasing antioxidants, apart from inhibition NF-κB pathways.Additionally, receptor activator factor-κB ligand (RANKL)-induced osteoclast differentiation function was remarkably suppressed [email protected] vitro observations, efficiently inhibited subchondral destruction acute arthritis model.Conclusion: By using MOSCs that are highly drug-loaded matrices first time, provides avenue severe designing drug-delivery systems subcellular targeting capacity.

Language: Английский

Citations

32

4‐octyl Itaconate inhibits lipopolysaccharide (LPS)‐induced osteoarthritis via activating Nrf2 signalling pathway DOI Creative Commons
Qingchen Zhang, Xiaohui Bai,

Rongrong Wang

et al.

Journal of Cellular and Molecular Medicine, Journal Year: 2022, Volume and Issue: 26(5), P. 1515 - 1529

Published: Jan. 23, 2022

Abstract Small molecule drug intervention for chondrocytes is a valuable method the treatment of osteoarthritis (OA). The 4‐octyl itaconate (OI) cellular derivative with sound cell permeability and transformation rate. We attempted to confirm protective role OI in its regulatory mechanism. used lipopolysaccharide (LPS) induce chondrocyte inflammation injury. After treatment, secretion mRNA expression Il ‐ 6 , 10 Mcp 1 Tnf α were detected by ELISA qPCR. effect on articular cartilage was further verified surgical destabilization medial meniscus model OA. Cell death apoptosis evaluated based CCK8, LDH, Typan blue staining, Annexin V TUNEL analyses. small interfering RNAs knockout Nrf2 gene verify OI‐mediated signalling pathway. results revealed that protects cells from LPS‐induced inflammatory injury attenuates induced LPS. Similar effects also observed mice. activated pathway promoted stable translocation into nucleus. When blocked, significantly counteracted mouse arthritis model. Both (i.e., OI) showed important medical

Language: Английский

Citations

30

Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease DOI
Darius J.R. Lane, Francesca M. Alves, Scott Ayton

et al.

Antioxidants and Redox Signaling, Journal Year: 2023, Volume and Issue: 39(1-3), P. 141 - 161

Published: May 22, 2023

Significance: The lack of disease-modifying treatments for Alzheimer’s disease (AD) that substantially alter the course highlights need new biological models progression and neurodegeneration. Oxidation macromolecules within brain, including lipids, proteins, DNA, is believed to contribute AD pathophysiology, concomitant with dysregulation redox-active metals, such as iron. Creating a unified model pathogenesis underpinned by iron redox in could lead therapeutic targets potential. Recent Advances: Ferroptosis, which was named 2012, necrotic form regulated cell death depends on both lipid peroxidation. While it distinct from other types death, ferroptosis regarded being mechanistically synonymous oxytosis. paradigm has great explanatory potential describing how neurons degenerate die AD. At molecular level, executed lethal accumulation phospholipid hydroperoxides generated iron-dependent peroxidation polyunsaturated fatty acids, while major defensive protein against selenoenzyme, glutathione peroxidase 4 (GPX4). An expanding network protective proteins pathways have also been identified complement GPX4 protection cells ferroptosis, central role emerging nuclear factor erythroid 2-related 2 (NRF2). Critical Issues: In this review, we provide critical overview utility NRF2 dysfunction understanding iron- peroxide-associated neurodegeneration Future Directions: Finally, discuss providing spectrum targets. Antioxid. Redox Signal. 39, 141–161.

Language: Английский

Citations

20

Injectable Hydrogel of Chitosan-Octyl Itaconate Conjugate Modulates Inflammatory Response DOI
Shasha Zhou, Jibing He, Quan Liu

et al.

ACS Biomaterials Science & Engineering, Journal Year: 2024, Volume and Issue: 10(8), P. 4823 - 4838

Published: July 26, 2024

Itaconic acid and its derivative 4-octyl itaconate (OI) represent a novel anti-inflammatory medication that has demonstrated efficacy in multiple inflammation models because of minimal side effects. Recently, natural polymers conjugated with small molecule drugs, known as polymer-drug conjugates (PDCs), have emerged promising approach to sustained drug release. In this work, we reported an prepare PDC containing OI make it into injectable hydrogel. Chitosan (CS) was selected for synthesis abundant free amino groups can be molecules carboxyl by carbodiimide chemistry. We used ethanol/water cosolvent system synthesize CS-OI conjugate via EDC/NHS catalysis. The had improved water solubility unique activity did not show compromised antibacterial compared unmodified CS. Beta-glycerophosphate (β-GP) cross-linked hydrogel exhibited good injectability sustainable release effectively modulated inflammatory response rat model. Therefore, study provides valuable insights the design hydrogels modulatory properties.

Language: Английский

Citations

6